AzTrials
AzTrials

ObesityPhase 1NCT04970589

Enhancing Efficacy of Mango Polyphenols in Lean and Obese

A Phase 1 study testing Mango and Probiotics in people with Obesity, run by Texas A&M University at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The objective of this research is to determine beneficial impact of mango phytochemicals in lean and obese individuals for cognitive function and gut health. Investigate how obesity impacts the efficacy of mango polyphenols on cognitive function and health. Read more about this study

Who is it for?
Ages 18 to 65 yearsHealthy volunteers can take part
Conditions the study is for
Obesity
What is being tested?
Mango and Probiotics
Type of treatment
Pill or oral medicine
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
100 participants
Where
1 siteUnited States
Study dates
30 Sep 2018to 28 Dec 2019
Phase
Phase 1
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Males or females
  • BMI between 18-23 and 27-35

Who cannot join

  • History of acute cardiac event, stroke, or cancer
  • Alcohol or substance abuse within the last 6 months
  • Pregnancy or lactation (or planned pregnancy)
  • No recurrent hospitalizations within the last 6 months
  • Allergy against any of the study treatments (mango or probiotics)
  • Liver or renal dysfunction
Show all 9Show fewer
  • Hepatitis B or C, HIV
  • Currently smoking more than 1 pack/week
  • History of dizziness/fainting during/after blood draws

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Texas A&M University

    College Station, Texas, 77845

Other trials in United States

About this study

Official title: Enhancing Efficacy of Mango Phytochemicals in Cognitive Function and Cardiometabolic Health in Lean and Obese

The objective of this research is to determine beneficial impact of mango phytochemicals in lean and obese individuals for cognitive function and gut health. Investigate how obesity impacts the efficacy of mango polyphenols on cognitive function and health. Investigate the ability of probiotic bacteria to optimize the absorption and efficacy of mango phytochemicals in lean and obese individuals.

Read the detailed description

Rationale: In obesity, interactions between adipocytes and macrophages are of increasing importance to understanding obesity and chronic diseases. Dietary compounds, such as polyphenols, are expected to cause significant changes in inflammatory biomarkers in lipid tissue that are different from those in blood. To capture any changes of macrophages interacting with lipid tissue and associated biomarkers, lipid biopsies were collected in this study.

Before the study day: Participants were advised to not eat anything after dinner at 7-8pm the night (A 12-hour fast). Drink plenty of water, at least 8 fl oz in the evening and 8 fl oz in the morning. Participants were advised to eat a well-balanced meal consisting of 25% protein-rich food, 25% whole grain high-fiber carbohydrate, and 50% fruits and vegetables prior to beginning of fast. Prior to the first study session, participants were asked to fill out a 72-h nutritional report with all food and drinks consumed using a website (www.mynetdiary.com)

Study day: Participants were asked to consume 400 g of cubed, fresh mango during the early morning hours of the study day starting right after the baseline blood draw. If they were in the placebo group, they were asked to take one placebo capsule daily. The placebo used in this study consisted of vegetable cellulose (HPMC USP) filled with 100% microcrystalline cellulose USP. If they were in the probiotic group, they were asked to take one capsule of the Renew Life Ultimate Flora "Extra Care" probiotic daily.

Study Treatment: In this study participants were placed into one of four different groups depending on their BMI. The study treatment depended on which study group they were in:

BMI 18-23, Group 1: They were asked to consume a single portion of 400g of mango and take one placebo capsule every day for the duration of the 8-week study.

BMI 18-23, Group 2: They were asked to consume a single portion of 400g of mango and take one probiotic capsule every day for the duration of the 8-week study.

BMI 27-35, Group 1: They were asked to consume a single portion of 400g of mango and take one placebo capsule every day for the duration of the 8-week study.

BMI 27-35, Group 2: They were asked to consume a single portion of 400g of mango and take one probiotic capsule every day for the duration of the 8-week study.

Subjects did not know if they received probiotic or placebo capsules as part of their study treatment. During all sessions, subjects were asked questions about their general health.

Study Session 1 (Days 1-3): Blood samples (30 mL or 6 teaspoons each) were taken before and 2 hours after mango consumption (Days 1, 2, and 3) by the study phlebotomist. Subjects were asked to collect approximately 3 fl. oz (half a cup) of urine in the morning of Days 1, 2, and 3, and 3 fl. ox (half a cup) in the evening of Days 1 and 2. They were also asked to collect a stool sample to bring on Day 1. The researchers gave the subjects containers for the urine and a kit for stool collection, as well as instructions on how to collect each of those samples. Instructions on how to transport those samples were also given to them. During Study Session 1 (Day 1), subjects took two cognitive function tests (Trail Making and Digit Span).

Study Session 2 (Day 29): The study phlebotomist collected a single blood sample (30 mL or 6 teaspoons) from the subject's arm. Participants were also asked to collect a stool sample using a collection kit we will provide.

NeuroTracker Sessions: During the last two weeks of the study (between days 43 and 56), subjects were asked to come to our facility to perform a total of ten sessions using the NeuroTracker, a cognitive function test. They could perform up to one session per day, and all ten sessions were completed between days 43 and 56. Before each session, subjects were asked to fill out the NeuroTracker questionnaire (to assess their emotional, mental, and physical state) and a food log.

Study Session 3 (Days 54-56): Blood samples (30 mL or 6 teaspoons each) were taken right before and 2 hours after mango consumption (Days 54, 55, and 56) by the study phlebotomist. Subjects were asked to collect approximately 3 fl. oz (half a cup) of urine in the morning of Days 54, 55, and 56, and 3 fl. ox (half a cup) in the evening of Days 54 and 55. They were also asked to collect a stool sample to bring on Day 54. The researchers gave the subjects containers for the urine and a kit for stool collection, as well as instructions on how to collect each of those samples. Instructions on how to transport those samples were also given to them. During this session (Day 54), subjects took two cognitive function tests (Trail Making and Digit Span). On Day 56, we measured the participant's body fat using an Omron Handheld Body Fat Monitor.

Cognitive Function Testing: On Days 1 and 54, we assessed the cognitive function of the subjects by giving them the following tests: The Trail Making Test (TMT A\&B) and the Wechsler Adult Scale-Revised Digit Span test.

During the last two weeks of the study (between days 43 and 56), subjects were also run through our NeuroTracker program. This was to test their spatial awareness. The TMT A\&B Test assesses measure of attention, speed, mental flexibility, spatial organization, visual pursuits, recall, and recognition. The Wechsler Adult Scale-Revised Digit Span is a measure of mental tracking, memory, and mental flexibility.

Lipid biopsy - Optional: This study included an optional lipid biopsy component and participants were free to agree to participate in this procedure at the beginning and end of this study.

This procedure was performed under supervision of the study physician Dr. Bramhal and performed by Dr. Jim Fluckey and Dr. Steven Riechman.

Conditions
Obesity
Being tested
Mango, Probiotics, Placebo
Medical subject headings
Obesity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • MangoOther

    400g of mango/day

  • ProbioticsDietary supplement

    1 probiotics capsule/day

  • PlaceboOther

    1 Placebo capsule/day

Study groups in NCT04970589
Study groupRoleWhat they receive
Lean/Placebo CapsulePlacebo comparatorParticipants (Lean:BMI 18-23) will be asked to take 400g of mango and a placebo capsule every day for 8 weeks
Receives: Other: Mango; Other: Placebo
Lean/ProbioticsExperimentalParticipants (Lean:BMI 18-23) will be asked to take 400g of mango and a probiotic capsule every day for 8 weeks
Receives: Other: Mango; Dietary Supplement: Probiotics
Obese/Placebo CapsuleExperimentalParticipants (Obese:BMI 27-35) will be asked to take 400g of mango and a placebo capsule every day for 8 weeks
Receives: Other: Mango; Other: Placebo
Obese/ProbioticsExperimentalParticipants (Obese:BMI 27-35) will be asked to take 400g of mango and a probiotic capsule every day for 8 weeks
Receives: Other: Mango; Dietary Supplement: Probiotics

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Cognitive Function (NeuroTracker)

    NeuroTracker: Ten sessions should be completed between days 43 and 56. Fill out the NeuroTracker questionnaire to assess their emotional, mental, and physical state.

    Measured: From Week 6 to Week 8

  2. Cognitive Function (The Trail Making Test)

    The Trail Making Test (TMT A\&B) On Days 1 and 54, Assessed the cognitive function of the subjects by giving them these tests. The TMT A\&B Test assesses measure of attention, speed, mental flexibility, spatial organization, visual pursuits, recall, and recognition.

    Measured: At baseline and week 8

  3. Cognitive Function (the Wechsler Adult Scale-Revised Digit Span test)

    The Wechsler Adult Scale-Revised Digit Span test: On Days 1 and 54, Assessed the cognitive function of the subjects by giving them these tests. The Wechsler Adult Scale-Revised Digit Span is a measure of mental tracking, memory, and mental flexibility.

    Measured: At baseline and week 8

Secondary outcomes (3)
  1. Changes from baseline in the levels of Inflammatory biomarkers in plasma

    Measure the Inflammatory biomarkers including TNF-a, IL-1b, IL-6, IL-8, IL-10.

    Measured: At baseline and week 8

  2. Change from baseline in the levels of metabolites of gallic acid in urine and plasma after mango intake.

    Aliquoted urine and plasma samples were thawed and centrifuged at 13,000 x g for 10 mins at 4°C immediately prior to analysis by HPLC-MSn. All quantification of metabolites (pyrogalloyl-O-glucuronide, O-methyl-gallic acid, O-methylgallic acid-O-sulfate, O-methylpyrogalloyl-O-sulfate, pyrogalloyl-O-sulfate, deoxypyrogallol-O-sulfate, O-methylpyrogalloyl-O-sulfate) was performed in full MS and expressed as gallic acid equivalents.

    Measured: At baseline and week 8

  3. Change from baseline in gut microbiota composition in stool samples

    16S rRNA-based pyrosequencing to quantify bacterial taxa

    Measured: At baseline and week 8

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Jul 2021
  2. Study start30 Sep 2018
  3. Primary completion30 Sep 2019
  4. Study completion28 Dec 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 1
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Factorial
Model description
Group 1: BMI 18-23: 400g of mango and a placebo capsule every day for 8 weeks Group 2: BMI 18-23: 400g of mango and a probiotic capsule every day for 8 weeks Group 3: BMI 27-35: 400g of mango and a placebo capsule every day for 8 weeks Group 4: BMI 27-35: 400g of mango and a probiotic capsule every day for 8 weeks
Masking
Single blind
Who is masked
Participant
Enrolment
100 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04970589
Sponsor's protocol ID
TexasAMU-IRB2018-0405F
Status last verified
Jul 2021
First submitted
6 Jul 2021
Last updated
21 Jul 2021
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A Phase 1 study testing Mango and Probiotics in people with Obesity, run by Texas A&M University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 21 Jul 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 1 studies test a treatment in a small group of people for the first time or in a new way, mainly to check safety and find the right dose.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Cognitive Function (NeuroTracker) (time frame: From Week 6 to Week 8). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Jul 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in